Boston Scientific (BSX) r&d spend was $2.1B in FY2025 (+27% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$2.1B
+27%
2024
$1.6B
+14%
2023
$1.4B
+7%
2022
$1.3B
+10%
2021
$1.2B
+5%
2020
$1.1B
-3%
2019
$1.2B
+5%
2018
$1.1B
+12%
2017
$997M
+8%
2016
$920M
+5%
2015
$876M
+7%
2014
$817M
-5%
2013
$861M
-3%
2012
$886M
-1%
2011
$895M
-5%
2010
$939M
-9%
2009
$1.0B
+3%
2008
$1.0B
-8%
2007
$1.1B
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$554M
Q1 2026
$516M
Q4 2025
$569M
Q3 2025
$514M
Q2 2025
$526M
Q1 2025
$443M
Q4 2024
$459M
Q3 2024
$407M
Q2 2024
$383M
Q1 2024
$366M
Q4 2023
$363M
Q3 2023
$356M
Source: BSX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.